
Cancer zzso aims to generate zzso zzso zzso immunity to limit zzso zzso progression and zzso zzso zzso has emerged as a critical checkpoint controlling the efficacy of zzso since it is the main access point for zzso T cells to reach zzso cell zzso zzso success has been particularly challenging to achieve because of the local, zzso inflammatory milieu that drives a zzso zzso supporting the growth and survival of zzso zzso Here, we focus on recent evidence that systemic zzso therapy can switch the activities of the inflammatory zzso zzso zzso to a predominantly zzso function that promotes zzso immunity by zzso T cell trafficking in the recalcitrant zzso zzso 

